Vericiguat for the treatment of coronary vasospasm (ViVA): a double-blind placebo-controlled randomized cross-over trial
Hanae F Namba, Elize A M de Jong, Aukelien C. Dimitriu-Leen, Martijn Meuwissen et autres
nl, gb, es (code pays fourni par la source)